Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Alexion_Pharmaceuticals
$1.2 billion |
| gptkbp:acquisitionYear |
2018
|
| gptkbp:developedDrug |
gptkb:SYNT001
|
| gptkbp:focusesOn |
rare diseases
autoimmune diseases |
| gptkbp:foundedBy |
gptkb:Burt_Adelman
gptkb:James_G._McArthur |
| gptkbp:foundedIn |
2013
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Syntimmune
|
| gptkbp:bfsParent |
gptkb:Apple_Tree_Partners
|
| gptkbp:bfsLayer |
6
|